Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin

Company announces yet a third offering for infant formula fortification, FBA, a compound which delivers butyrate to the infant gut while retaining the accepted flavor of formula for babies’ palates.

Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human milk oligosaccharide (HMO.)

Human lactoferrin is a critical iron-binding compound for immunity and iron nutrition. HMOs are important nutritional compounds only found in human milk. The most abundant HMO in human milk is 2’-fucosyllactose (2’FL), and it is responsible for promoting good gut bacteria, strengthening the gut barrier function, and suppressing pathogens.

“Conagen is honored to accept this award from SynBioBeta for our human lactoferrin and non-GMO HMO infant formula ingredients, but we do not intend to stop there. We are dedicated to continuously improving infant health and nutrition by expanding

Read More